Get the tools used by (smart)2 investors.
Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PBE: Invesco Biotechnology & Genome ETF

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. It invests in public equity markets of the Un...

64.15 USD
Price
USD
Fair Value
Upside
59.32 - 72.84
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Invesco Biotechnology & Genome ETF's Altman Z-Score:

Apr 2016Apr 2018Apr 2020Apr 2022Apr 20240.0

Performance Summary

    How does Invesco Dynamic Biotechnology & Genome's Altman Z-Score benchmark against competitors?

    Hide this widget

    We've identified the following companies as similar to Invesco Biotechnology & Genome ETF because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

    Metric Usage: Altman Z-Score

    Hide this widget
    altman_z_score
    Slug
    number
    Datatype
    text
    Format
    current
    Default Period
    FY, LTM
    Periods Supported
    Free
    Plan

    To view the full list of supported financial metrics please see Complete Metrics Listing.

    Similar Metrics

    Hide this widget

    Metrics similar to Altman Z-Score in the risk category include:

    • Beneish M-Score - A statistical score that uses financial ratios to identify whether a company has manipulated its earnings
    • Debt / Equity, Adjusted - A ratio that measures the level of the debt relative to the book value of common equity plus the absolute value of treasury stock.
    • Quick Ratio - A ratio used to assess a company's short-term liquidity.
    • Beta (5 Year) - A ratio that measures the risk or volatility of a company's share price in comparison to the market as a whole. A beta of 1.0 means that the company rises and falls in direct relationship to the movement of the benchmark index. A beta that is less than 1 indicates a stock that is less volatile than the overall market and a beta greater than 1 indicates that the stock is more volatile.
    View Full List

    Search for metric or datapoint

    Altman Z-Score

    A formula used to predict the probability that a firm will go into bankruptcy within two years.

    Definition of Altman Z-Score

    Hide this widget

    Altman Z-Score is a formula used to predict the probability that a firm will go into bankruptcy within two years. The original paper by Professor Edward I. Altman can be found here.

    The formula for Z-Score is as follows:

    Z = 1.2A + 1.4B + 3.3C + 0.6D + 1.0E
    
    A = Working Capital / Total Assets
    B = Retained Earnings / Total Assets
    C = EBIT / Total Assets
    D = Market Value Of Equity / Book Value Of Total Liabilities
    E = Sales / Total Assets
    

    For non-U.S. and financial institutions, a modified version of the formula called Z"-Score is used.

    Z" = 6.56A + 3.26B + 6.72C + 1.05D + 3.25
    
    A = Working Capital / Total Assets
    B = Retained Earnings / Total Assets
    C = Operating Income / Total Assets
    D = Book Value of Equity / Book Value Of Liabilities
    

    The formula for Z-Score is as follows:

    Z-Score:
      Z > 2.99            |   Safe Zone
      2.99 > Z > 1.81     |   Gray Zone
      Z < 1.81            |   Distress Zone
    
    Z"-Score:
      Z > 2.6             |  Safe Zone
      2.6 > Z > 1.1       |  Gray Zone
      Z < 1.1             |  Distress Zone
    

    Click the link below to download a spreadsheet with an example Altman Z-Score calculation for Invesco Biotechnology & Genome ETF below:

    Sector Benchmark Analysis

    Sector
    Industry Group
    Industry
    Hide this widget
    -137.212.8162.8411.52006001,000

    The chart above depicts the distribution of altman z-score for companies operating in the Financials sector in the Developed economic region. Over 2,820 companies were considered in this analysis, and 2,712 had meaningful values. The average altman z-score of companies in the sector is 11.5 with a standard deviation of 42.2.

    Invesco Biotechnology & Genome ETF's Altman Z-Score of - ranks in the - percentile for the sector. The following table provides additional summary stats:

    Altman Z-Score In The Financials Sector
    Economic Risk RegionDeveloped
    Total Constituents2,826
    Included Constituents2,712
    Min-139.6
    Max407.3
    Median2.9
    Mean11.5
    Standard Deviation42.2

    You can find companies with similar altman z-score using this stock screener.

    All rights reserved. Terms Of Use